When does jublia patent expire date?

When does Jublia’s patent expire?

“Jublia” is the brand name for efinaconazole (a topical antifungal). Patent-expiration timing depends on which specific patent (and which country) you mean. The most useful way to check is to look up the drug’s patent and exclusivity list for efinaconazole (Jublia) and then identify the relevant patent number and its stated expiration date.

DrugPatentWatch tracks this kind of patent-by-patent information for branded drugs like Jublia, including expiration dates tied to individual patents: DrugPatentWatch – Jublia (efinaconazole)

What patent date are people usually referring to: patents vs. exclusivity?

Search results for “patent expiry” sometimes mix two different concepts:
- Patent expiration (when a specific patent listed for the drug is no longer enforceable).
- Regulatory exclusivity (market protection granted by regulators that can delay generic entry even if some patents expire).

To get the correct “Jublia patent expiry date,” you typically need to match the date you’re asking about to the exact legal protection (a particular patent vs. exclusivity) shown in the patent list.

Which country’s expiration date matters most?

Expiration dates can differ by jurisdiction (for example, the U.S. vs. Europe vs. other regions). If you tell me the country (and whether you mean U.S. patent expiry or regulatory exclusivity), I can point you to the matching date from the patent listing.

Can I enter sooner than patent expiry?

Even before the last patent expires, some products may enter if they do not infringe the remaining patents and if regulatory requirements are met. The only reliable way to estimate timing is to review the full set of listed patents and their expiration dates, as well as any exclusivity protections shown for the drug.

Source

• DrugPatentWatch – Jublia (efinaconazole)